Synfacts, Table of Contents Synfacts 2023; 19(03): 0309DOI: 10.1055/s-0042-1753318 Innovative Drug Discovery and Development Potent and Selective PARP7 Inhibitor, KMR-206, Regulates IFN-I Signaling Authors Contributor(s): Dirk Trauner Yingfang Wang Recommend Article Abstract Buy Article(opens in new window)Key words Key wordsPARP7 inhibitor - IFN-I signaling - immune-oncology Full Text
